Helixgate https://validator.w3.org/feed/docs/rss2.html GSK to Acquire Nuvalent for $10.6B, Boosting Cancer Pipeline with Precision NSCLC Treatments Origins of First Eukaryotes Linked to Contributions from Multiple Bacteria and Giant Viruses Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust Symeres Expands Spray Drying Capabilities at Its U.S. New Jersey Site STAT+: Your sepsis algorithm shouldn’t require a time machine In Silico Devices May Improve Drug Manufacturability Gorilla Adenovirus Brings Natural Edge to Cancer Therapy Sanofi stops immune drug trial in latest research setback OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations mRNA Tails Play Key Role in Folding Regulatory Proteins STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more Sanofi cans late-stage study for rare autoimmune disease on underwhelming efficacy Disc’s FDA meeting sets ‘clear path’ for embattled rare blood disease drug The State of Biologics Testing 2026 Update: Parabilis raises industry-record $670M IPO DOJ reaches second settlement on youth gender care Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care Local trade groups must support life sciences in these difficult times Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity T-Cell Synapse Formation Is Restrained by PTPN22–PSTPIP1 Signaling Home STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis finds Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts Merck, Gilead report mixed outcomes in key lung cancer, HIV studies Trump administration warns more than 500 hospitals to provide more price information or face fines Complete Connectome of Fruit Fly Central Nervous System Now Open-Source Crystalys doses first patients in Phase II gout trial  Four years and 219 lost companies later, biotech still has a cash problem STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble STAT+: NIH staffers published a letter of dissent a year ago. They feel it’s been ignored ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data STAT+: What’s changed since the last major Ebola outbreak GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval Opinion: Why STAT is sticking with ‘health care’ as two words Fueled by M&A and partnerships, biotech is poised for continued growth: EY STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B Alcohol study discarded by Trump officials is published in scientific journal Defective HIV RNA Linked to Persistent Viremia During Long-Term ART Hybrid solid−liquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest City banks nearly $100M for next-gen RNAi drugs Regeneron-backed City builds RNAi pipeline with $99.5M series B